NCT01484873View on ClinicalTrials.gov

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
ObesityOverweightCraniopharyngioma
Interventions
DRUG

Exenatide

Treatment with exenatide 5 mcg twice daily for 4 weeks, then 10 mcg twice daily for 46 weeks.

Trial Locations (1)

37232

Vanderbilt University, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT01484873 - Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor | Biotech Hunter | Biotech Hunter